This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chilosi, M. Articles by Inghirami, G. Search for Related Content PubMed PubMed Citation Articles by Chilosi, M. Articles by Inghirami, G.

American Journal of Pathology, Vol 152, 209-217, Copyright © 1998 by American Society for Investigative Pathology

REGULAR ARTICLES

Differential expression of cyclin-dependent kinase 6 in cortical thymocytes and T-cell lymphoblastic lymphoma/leukemia

M Chilosi, C Doglioni, Z Yan, M Lestani, F Menestrina, C Sorio, A Benedetti, F Vinante, G Pizzolo and G Inghirami
Istituto di Anatomia Patologica, Universita di Verona, Italy. marco@anpat.univ.it

Cyclin-dependent kinase-6 (CDK6) is the earliest inducible member of the CDK family in human T lymphocytes, involved in growth factor stimulation and cell cycle progression. CDK6 is one of the targets of p16 and p15, CDK inhibitors encoded by MTS1 and MTS2, two tumor suppressor genes that are frequently deleted in T-cell leukemia. In this study we have investigated CDK6 expression in normal and neoplastic lymphoid tissues using immunohistochemistry and flow cytometry. In normal (six samples) and hyperplastic (four samples) thymuses, strong CDK6 expression was observed in a discrete proportion of cortical thymocytes (10 to 15%), mainly located in the peripheral (subcapsular) zone of the cortex. All tested cases of T-cell lymphoblastic lymphoma/leukemia (T-LBL/ALL) showed strong CDK6 expression in the majority (up to 100%) of neoplastic lymphoid cells. Western blot analysis confirmed the expected CDK6 protein size (40 kd). According to Southern blot analysis, CDK6 overexpression in neoplastic T lymphoblasts was not due to gene amplification. In all other lymphomas investigated (28 peripheral T-cell non-Hodgkin's lympohomas (T-NHLs), 7 CD30+ anaplastic NHLs, 22 high-grade B-NHLs, 15 low-grade B- NHLs, 25 B-cell precursor ALLs), CDK6 was not expressed or expressed at low levels, with the only exception of three nasal angiocentric T-NHLs, all exhibiting CDK6 immunoreactivity comparable to that observed in T- LBL/ALL. These data provide evidence that CDK6 is abnormally expressed in T-LBL/ALL and may be involved in the pathogenesis of this malignancy. In addition, the quantitative difference of CDK6 expression between neoplastic and non-neoplastic cortical thymocytes can be potentially useful in the differential diagnosis of thymic neoplasms on histological and cytological specimens.

This article has been cited by other articles:

				S. H. Peterson, D. T. Nardelli, T. F. Warner, S. M. Callister, J. R. Torrealba, and R. F. Schell Anti-p19 Antibody Treatment Exacerbates Lyme Arthritis and Enhances Borreliacidal Activity Clin. Vaccine Immunol., May 1, 2007; 14(5): 510 - 517. [Abstract] [Full Text] [PDF]

				J.-Y. Koo, I. Sohn, S. Kim, and J. W. Lee Structured polychotomous machine diagnosis of multiple cancer types using gene expression Bioinformatics, April 15, 2006; 22(8): 950 - 958. [Abstract] [Full Text] [PDF]

				F. Mendrzyk, B. Radlwimmer, S. Joos, F. Kokocinski, A. Benner, D. E. Stange, K. Neben, H. Fiegler, N. P. Carter, G. Reifenberger, et al. Genomic and Protein Expression Profiling Identifies CDK6 As Novel Independent Prognostic Marker in Medulloblastoma J. Clin. Oncol., December 1, 2005; 23(34): 8853 - 8862. [Abstract] [Full Text] [PDF]

				G. Z. Rassidakis, R. Lai, M. Herling, C. Cromwell, A. Schmitt-Graeff, and L. J. Medeiros Retinoblastoma Protein Is Frequently Absent or Phosphorylated in Anaplastic Large-Cell Lymphoma Am. J. Pathol., June 1, 2004; 164(6): 2259 - 2267. [Abstract] [Full Text] [PDF]

				J. J. Lucas, J. Domenico, and E. W. Gelfand Cyclin-Dependent Kinase 6 Inhibits Proliferation of Human Mammary Epithelial Cells Mol. Cancer Res., February 1, 2004; 2(2): 105 - 114. [Abstract] [Full Text] [PDF]

				L. J. Raffini, D. J. Slater, E. F. Rappaport, L. Lo Nigro, N.-K. V. Cheung, J. A. Biegel, P. C. Nowell, B. J. Lange, and C. A. Felix Panhandle and reverse-panhandle PCR enable cloning of der(11) and der(other) genomic breakpoint junctions of MLL translocations and identify complex translocation of MLL, AF-4, and CDK6 PNAS, April 2, 2002; 99(7): 4568 - 4573. [Abstract] [Full Text] [PDF]

				A. Walentinsson, K. Helou, V. Wallenius, H. J. Hedrich, C. Szpirer, and G. Levan Independent Amplification of Two Gene Clusters on Chromosome 4 in Rat Endometrial Cancer: Identification and Molecular Characterization Cancer Res., November 1, 2001; 61(22): 8263 - 8273. [Abstract] [Full Text] [PDF]

				C.-W. Lin, W.-H. Lee, C.-L. Chang, J.-Y. Yang, and S.-M. Hsu Restricted Killer Cell Immunoglobulin-Like Receptor Repertoire without T-Cell Receptor {gamma} Rearrangement Supports a True Natural Killer-Cell Lineage in a Subset of Sinonasal Lymphomas Am. J. Pathol., November 1, 2001; 159(5): 1671 - 1679. [Abstract] [Full Text] [PDF]

				I. Matushansky, F. Radparvar, and A. I. Skoultchi Reprogramming leukemic cells to terminal differentiation by inhibiting specific cyclin-dependent kinases in G1 PNAS, December 8, 2000; (2000) 250488697. [Abstract] [Full Text]

				I. Matushansky, F. Radparvar, and A. I. Skoultchi Manipulating the onset of cell cycle withdrawal in differentiated erythroid cells with cyclin-dependent kinases and inhibitors Blood, October 15, 2000; 96(8): 2755 - 2764. [Abstract] [Full Text] [PDF]

				I. Matushansky, F. Radparvar, and A. I. Skoultchi Reprogramming leukemic cells to terminal differentiation by inhibiting specific cyclin-dependent kinases in G1 PNAS, December 19, 2000; 97(26): 14317 - 14322. [Abstract] [Full Text] [PDF]